Patents by Inventor Andreani Odysseos

Andreani Odysseos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTIFUNCTIONAL CONJUGATES
    Publication number: 20230027148
    Abstract: The present invention provides compounds suitable for use in the treatment of conditions where it is beneficial to halt bone loss and kill cancer cells, particularly in metastases to and primary tumors in the bone and surrounding tissues. Consequently the present invention provides compounds comprising a bisphosphonate moiety linked to a phytochemical, pharmaceutical compositions thereof and methods of treatment of bone diseases and/or proliferative disorders.
    Type: Application
    Filed: July 8, 2022
    Publication date: January 26, 2023
    Inventors: Andreani Odysseos, Andreas Evdokiou, Anstasios Keramidas
  • Multifunctional conjugates
    Patent number: 11400160
    Abstract: The present invention provides compounds suitable for use in the treatment of conditions where it is beneficial to halt bone loss and kill cancer cells, particularly in metastases to and primary tumours in the bone and surrounding tissues. Consequently the present invention provides compounds comprising a bisphosphonate moiety linked to a phytochemical, pharmaceutical compositions thereof and methods of treatment of bone diseases and/or proliferative disorders.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: August 2, 2022
    Assignee: E.P.O.S IASIS Research and Development Limited
    Inventors: Andreani Odysseos, Andreas Evdokiou, Anastasios Keramidas
  • MULTIFUNCTIONAL CONJUGATES
    Publication number: 20200164076
    Abstract: The present invention provides compounds suitable for use in the treatment of conditions where it is beneficial to halt bone loss and kill cancer cells, particularly in metastases to and primary tumours in the bone and surrounding tissues. Consequently the present invention provides compounds comprising a bisphosphonate moiety linked to a phytochemical, pharmaceutical compositions thereof and methods of treatment of bone diseases and/or proliferative disorders.
    Type: Application
    Filed: July 5, 2017
    Publication date: May 28, 2020
    Inventors: Andreani Odysseos, Andreas Evdokiou, Anastasios Keramidas
  • Prototype systems of theranostic biomarkers for in vivo molecular management of cancer
    Patent number: 10640524
    Abstract: The present invention relates to a theranostic system comprising a beacon and a compound selected from the group consisting of a quinazoline-based tyrosine kinase inhibitor and a natural product. The theranostic systems have use in the therapy and diagnosis of tyrosine kinase related malignancies.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: May 5, 2020
    Assignee: EPOS-IASIS RESEARCH AND DEVELOPMNT, LTD
    Inventors: Andreani Odysseos, Costas Pitris, Anastasios Keramidas
  • PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER
    Publication number: 20180170953
    Abstract: The present invention relates to a theranostic system comprising a beacon and a compound selected from the group consisting of a quinazoline-based tyrosine kinase inhibitor and a natural product. The theranostic systems have use in the therapy and diagnosis of tyrosine kinase related malignancies.
    Type: Application
    Filed: January 10, 2018
    Publication date: June 21, 2018
    Inventors: Andreani ODYSSEOS, Costas PITRIS, Anastasios KERAMIDAS
  • Prototype systems of theranostic biomarkers for in vivo molecular management of cancer
    Patent number: 9890187
    Abstract: The present invention relates to a theranostic system comprising a beacon and a compound selected from the group consisting of a quinazoline-based tyrosine kinase inhibitor and a natural product. The theranostic systems have use in the therapy and diagnosis of tyrosine kinase related malignancies.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: February 13, 2018
    Assignee: EPOS-IASIS RESEARCH AND DEVELOPMENT, LTD.
    Inventors: Andreani Odysseos, Costas Pitris, Anastasios Keramidas
  • PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER
    Publication number: 20160376298
    Abstract: The present invention relates to a theranostic system comprising a beacon and a compound selected from the group consisting of a quinazoline-based tyrosine kinase inhibitor and a natural product. The theranostic systems have use in the therapy and diagnosis of tyrosine kinase related malignancies.
    Type: Application
    Filed: June 26, 2015
    Publication date: December 29, 2016
    Inventors: Andreani ODYSSEOS, Costas PITRIS, Anastasios KERAMIDAS
  • Tocopherol ester compounds
    Patent number: 6716873
    Abstract: Disclosed are novel tocopherol ester compounds having the formula wherein X is a chain of 2 or 3 carbon atoms, e.g., ethylene and trimethylene, joining the 2 carbonyl groups to which they are bonded; and R1 is a group having the formula —Y—R4 wherein Y is a selenium, tellurium or sulfur atom and R4 is an alkyl, cycloalkyl or aryl radical. The tocopherol ester compounds of formula (I) exhibit antiproliferative and growth inhibitory effects on breast cancer cell lines.
    Type: Grant
    Filed: March 20, 2003
    Date of Patent: April 6, 2004
    Assignee: Yasoo Health Inc.
    Inventors: Anastasios Keramidas, Andreani Odysseos, Andreas Michael Papas